T1	Participants 58 106	patients with acquired immunodeficiency syndrome
T2	Participants 165 252	The Studies of Ocular Complications of AIDS Research Group. AIDS Clinical Trials Group.
T3	Participants 428 608	Two hundred nine patients with acquired immunodeficiency syndrome and active CMV retinitis were enrolled in a multicenter, phase 2/3, randomized, placebo-controlled clinical trial.
